{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T14:30:37Z","timestamp":1782570637862,"version":"3.54.5"},"reference-count":79,"publisher":"e-Century Publishing Corporation","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/mypg4066","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T03:35:57Z","timestamp":1727667357000},"page":"4265-4285","source":"Crossref","is-referenced-by-count":1,"title":["Lespedeza bicolor root extract exerts anti-TNBC potential by regulating FAK-related signalling pathways"],"prefix":"10.62347","volume":"14","author":[{"given":"Zijun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S and Soerjomataram I. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 2022; 66: 15-23.","journal-title":"Breast"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"20211033","DOI":"10.1259\/bjr.20211033","article-title":"Understanding breast cancer as a global health concern","volume":"95","author":"Wilkinson","year":"2022","unstructured":"Wilkinson L and Gathani T. Understanding breast cancer as a global health concern. Br J Radiol 2022; 95: 20211033.","journal-title":"Br J Radiol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","unstructured":"Yin L, Duan JJ, Bian XW and Yu SC. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res 2020; 22: 61.","journal-title":"Breast Cancer Res"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.ajpath.2017.04.022","article-title":"Breast cancer molecular stratification: from intrinsic subtypes to integrative clusters","volume":"187","author":"HG","year":"2017","unstructured":"Russnes HG, Lingjærde OC, Børresen-Dale AL and Caldas C. Breast cancer molecular stratification: from intrinsic subtypes to integrative clusters. Am J Pathol 2017; 187: 2152-2162.","journal-title":"Am J Pathol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10549-010-1293-1","article-title":"Triple negative breast cancer: unmet medical needs","volume":"125","author":"SK","year":"2011","unstructured":"Pal SK, Childs BH and Pegram M. Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat 2011; 125: 627-636.","journal-title":"Breast Cancer Res Treat"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Yao H, He G, Yan S, Chen C, Song L, Rosol TJ and Deng X. Triple-negative breast cancer: is there a treatment on the horizon? Oncotarget 2017; 8: 1913-1924.","DOI":"10.18632\/oncotarget.12284"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41523-020-00197-2","article-title":"Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies","volume":"6","author":"Marra","year":"2020","unstructured":"Marra A, Trapani D, Viale G, Criscitiello C and Curigliano G. Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies. NPJ Breast Cancer 2020; 6: 54.","journal-title":"NPJ Breast Cancer"},{"key":"ref7","unstructured":"Aysola K, Desai A, Welch C, Xu J, Qin Y, Reddy V, Matthews R, Owens C, Okoli J, Beech DJ, Piyathilake CJ, Reddy SP and Rao VN. Triple negative breast cancer - an overview. Hereditary Genet 2013; 2013 Suppl 2: 001."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.25122\/jml-2021-0108","article-title":"Triple-negative breast cancer: current treatment strategies and factors of negative prognosis","volume":"15","author":"Baranova","year":"2022","unstructured":"Baranova A, Krasnoselskyi M, Starikov V, Kartashov S, Zhulkevych I, Vlasenko V, Oleshko K, Bilodid O, Sadchikova M and Vinnyk Y. Triple-negative breast cancer: current treatment strategies and factors of negative prognosis. J Med Life 2022; 15: 153-161.","journal-title":"J Med Life"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1093\/annonc\/mdp492","article-title":"Triple-negative breast cancer--current status and future directions","volume":"20","author":"Gluz","year":"2009","unstructured":"Gluz O, Liedtke C, Gottschalk N, Pusztai L, Nitz U and Harbeck N. Triple-negative breast cancer--current status and future directions. Ann Oncol 2009; 20: 1913-1927.","journal-title":"Ann Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3390\/cells8090957","article-title":"Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge","volume":"8","author":"Nedeljkovi&#x107","year":"2019","unstructured":"Nedeljković M and Damjanović A. Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge. Cells 2019; 8: 957.","journal-title":"Cells"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME and Gianni L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 2016; 13: 674-690.","journal-title":"Nat Rev Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1200\/JCO.2014.57.6660","article-title":"TBCRC009: a multicenter phase II clinical trial of platinum monotherapy with biomarker assessment in metastatic triple-negative breast cancer","volume":"33","author":"Isakoff","year":"2015","unstructured":"Isakoff SJ, Mayer EL, He L, Traina TA, Carey LA, Krag KJ, Rugo HS, Liu MC, Stearns V, Come SE, Timms KM, Hartman AR, Borger DR, Finkelstein DM, Garber JE, Ryan PD, Winer EP, Goss PE and Ellisen LW. TBCRC009: a multicenter phase II clinical trial of platinum monotherapy with biomarker assessment in metastatic triple-negative breast cancer. J Clin Oncol 2015; 33: 1902-1909.","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s13237-022-00405-3","article-title":"Plant-derived natural products for drug discovery: current approaches and prospects","volume":"65","author":"Nasim","year":"2022","unstructured":"Nasim N, Sandeep IS and Mohanty S. Plant-derived natural products for drug discovery: current approaches and prospects. Nucleus (Calcutta) 2022; 65: 399-411.","journal-title":"Nucleus (Calcutta)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: a review","volume":"33","author":"Atanasov","year":"2015","unstructured":"Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, Linder T, Wawrosch C, Uhrin P, Temml V, Wang L, Schwaiger S, Heiss EH, Rollinger JM, Schuster D, Breuss JM, Bochkov V, Mihovilovic MD, Kopp B, Bauer R, Dirsch VM and Stuppner H. Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol Adv 2015; 33: 1582-1614.","journal-title":"Biotechnol Adv"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1002\/ptr.7099","article-title":"Natural products: a lead for drug discovery and development","volume":"35","author":"Chopra","year":"2021","unstructured":"Chopra B and Dhingra AK. Natural products: a lead for drug discovery and development. Phytother Res 2021; 35: 4660-4702.","journal-title":"Phytother Res"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Sarin N, Engel F, Kalayda GV, Mannewitz M, Cinatl J Jr, Rothweiler F, Michaelis M, Saafan H, Ritter CA, Jaehde U and Frötschl R. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2\/M cell cycle arrest. PLoS One 2017; 12: e0181081.","DOI":"10.1371\/journal.pone.0181081"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.15430\/JCP.2015.20.4.223","article-title":"Natural products for chemoprevention of breast cancer","volume":"20","author":"EY","year":"2015","unstructured":"Ko EY and Moon A. Natural products for chemoprevention of breast cancer. J Cancer Prev 2015; 20: 223-231.","journal-title":"J Cancer Prev"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Gupta N, Kumar H, Gupta S, S M B and Saini K. A concise review on natural products and their derivatives for breast cancer treatment. Chem Biodivers 2023; 20: e202300688.","DOI":"10.1002\/cbdv.202300688"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13659-014-0048-9","article-title":"Anti-breast cancer agents derived from plants","volume":"5","author":"Levitsky","year":"2014","unstructured":"Levitsky DO and Dembitsky VM. Anti-breast cancer agents derived from plants. Nat Prod Bioprospect 2014; 5: 1-16.","journal-title":"Nat Prod Bioprospect"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12906-018-2148-2","article-title":"Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K\/AKT\/mTOR signaling pathway","volume":"18","author":"Zhou","year":"2018","unstructured":"Zhou R, Chen H, Chen J, Chen X, Wen Y and Xu L. Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K\/AKT\/mTOR signaling pathway. BMC Complement Altern Med 2018; 18: 83.","journal-title":"BMC Complement Altern Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"18457","DOI":"10.1038\/srep18457","article-title":"Anti-breast tumor activity of Eclipta extract in-vitro and in-vivo: novel evidence of endoplasmic reticulum specific localization of Hsp60 during apoptosis","volume":"5","author":"Arya","year":"2015","unstructured":"Arya RK, Singh A, Yadav NK, Cheruvu SH, Hossain Z, Meena S, Maheshwari S, Singh AK, Shahab U, Sharma C, Singh K, Narender T, Mitra K, Arya KR, Singh RK, Gayen JR and Datta D. Anti-breast tumor activity of Eclipta extract in-vitro and in-vivo: novel evidence of endoplasmic reticulum specific localization of Hsp60 during apoptosis. Sci Rep 2015; 5: 18457.","journal-title":"Sci Rep"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Luo H, Zhao L, Li Y, Xia B, Lin Y, Xie J, Wu P, Liao D, Zhang Z and Lin L. An in vivo and in vitro assessment of the anti-breast cancer activity of crude extract and fractions from Prunella vulgaris L. Heliyon 2022; 8: e11183.","DOI":"10.1016\/j.heliyon.2022.e11183"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2022.12.007","article-title":"Lespedeza bicolor extract supplementation reduced hyperglycemia-induced skeletal muscle damage by regulation of AMPK\/SIRT\/PGC1α-related energy metabolism in type 2 diabetic mice","volume":"110","author":"Lee","year":"2023","unstructured":"Lee H, Kim SY and Lim Y. Lespedeza bicolor extract supplementation reduced hyperglycemia-induced skeletal muscle damage by regulation of AMPK\/SIRT\/PGC1α-related energy metabolism in type 2 diabetic mice. Nutr Res 2023; 110: 1-13.","journal-title":"Nutr Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.sjbs.2015.01.016","article-title":"A potential anti-inflammation activity and depigmentation effect of Lespedeza bicolor extract and its fractions","volume":"23","author":"SJ","year":"2016","unstructured":"Lee SJ, Hossaine MD and Park SC. A potential anti-inflammation activity and depigmentation effect of Lespedeza bicolor extract and its fractions. Saudi J Biol Sci 2016; 23: 9-14.","journal-title":"Saudi J Biol Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0254-6272(17)30150-4","article-title":"Methanolic extract from Lespedeza bicolor: potential candidates for natural antioxidant and anticancer agent","volume":"37","author":"Sami","year":"2017","unstructured":"Sami U. Methanolic extract from Lespedeza bicolor: potential candidates for natural antioxidant and anticancer agent. J Tradit Chin Med 2017; 37: 444-451.","journal-title":"J Tradit Chin Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/biom10030451","article-title":"Polyphenolic compounds from lespedeza bicolor root bark inhibit progression of human prostate cancer cells via induction of apoptosis and cell cycle arrest","volume":"10","author":"Dyshlovoy","year":"2020","unstructured":"Dyshlovoy SA, Tarbeeva D, Fedoreyev S, Busenbender T, Kaune M, Veselova M, Kalinovskiy A, Hauschild J, Grigorchuk V, Kim N, Bokemeyer C, Graefen M, Gorovoy P and von Amsberg G. Polyphenolic compounds from lespedeza bicolor root bark inhibit progression of human prostate cancer cells via induction of apoptosis and cell cycle arrest. Biomolecules 2020; 10: 451.","journal-title":"Biomolecules"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1055\/a-2114-0980","article-title":"1-methoxyerythrabyssin II induces autophagy in leukemia cells via PI3K\/Akt\/mTOR pathways","volume":"89","author":"Fang","year":"2023","unstructured":"Fang B, Kim S, Kim Y, Qiu Y, Lee CM, Lai Y, Liu Z, Wang K and Cho N. 1-methoxyerythrabyssin II induces autophagy in leukemia cells via PI3K\/Akt\/mTOR pathways. Planta Med 2023; 89: 1204-1214.","journal-title":"Planta Med"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Chaudhry GES, Akim AM, Sung YY and Muhammad TST. Cancer and apoptosis. Apoptosis and Cancer: Methods and Protocols. Springer; 2022. pp. 191-210.","DOI":"10.1007\/978-1-0716-2553-8_16"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3389\/fphar.2019.01614","article-title":"Phytochemicals in cancer treatment: from preclinical studies to clinical practice","volume":"10","author":"Choudhari","year":"2020","unstructured":"Choudhari AS, Mandave PC, Deshpande M, Ranjekar P and Prakash O. Phytochemicals in cancer treatment: from preclinical studies to clinical practice. Front Pharmacol 2020; 10: 1614.","journal-title":"Front Pharmacol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1089\/ars.2012.4938","article-title":"New insights into the link between DNA damage and apoptosis","volume":"19","author":"Zio D","year":"2013","unstructured":"De Zio D, Cianfanelli V and Cecconi F. New insights into the link between DNA damage and apoptosis. Antioxid Redox Signal 2013; 19: 559-571.","journal-title":"Antioxid Redox Signal"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1667\/RR13572.1","article-title":"Role of 53BP1 in the regulation of DNA double-strand break repair pathway choice","volume":"181","author":"Gupta","year":"2014","unstructured":"Gupta A, Hunt CR, Chakraborty S, Pandita RK, Yordy J, Ramnarain DB, Horikoshi N and Pandita TK. Role of 53BP1 in the regulation of DNA double-strand break repair pathway choice. Radiat Res 2014; 181: 1-8.","journal-title":"Radiat Res"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1042\/EBC20190012","article-title":"Cell matrix adhesion in cell migration","volume":"63","author":"Conway","year":"2019","unstructured":"Conway JRW and Jacquemet G. Cell matrix adhesion in cell migration. Essays Biochem 2019; 63: 535-551.","journal-title":"Essays Biochem"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/biom10020179","article-title":"FAK structure and regulation by membrane interactions and force in focal adhesions","volume":"10","author":"Mart&#xED","year":"2020","unstructured":"Tapial Martínez P, López Navajas P and Lietha D. FAK structure and regulation by membrane interactions and force in focal adhesions. Biomolecules 2020; 10: 179.","journal-title":"Biomolecules"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Hall JE, Fu W and Schaller MD. Chapter five - focal adhesion kinase: exploring fak structure to gain insight into function. In: Jeon KW, editors. International Review of Cell and Molecular Biology. Academic Press; 2011. pp. 185-225.","DOI":"10.1016\/B978-0-12-386041-5.00005-4"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/jclinpath-2012-201085","article-title":"Ki67 and proliferation in breast cancer","volume":"66","author":"Pathmanathan","year":"2013","unstructured":"Pathmanathan N and Balleine RL. Ki67 and proliferation in breast cancer. J Clin Pathol 2013; 66: 512-516.","journal-title":"J Clin Pathol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/leu.2010.6","article-title":"gammaH2AX: a sensitive molecular marker of DNA damage and repair","volume":"24","author":"Mah","year":"2010","unstructured":"Mah LJ, El-Osta A and Karagiannis TC. gammaH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 2010; 24: 679-686.","journal-title":"Leukemia"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nrc3792","article-title":"FAK in cancer: mechanistic findings and clinical applications","volume":"14","author":"FJ","year":"2014","unstructured":"Sulzmaier FJ, Jean C and Schlaepfer DD. FAK in cancer: mechanistic findings and clinical applications. Nat Rev Cancer 2014; 14: 598-610.","journal-title":"Nat Rev Cancer"},{"key":"ref38","unstructured":"Gowda S, Desai PB, Kulkarni SS, Hull VV, Math AA and Vernekar SN. Markers of renal function tests. N Am J Med Sci 2010; 2: 170-173."},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Tavares DF, Chaves Ribeiro V, Andrade MAV, Moreira Cardoso-Júnior L, Rhangel Gomes Teixeira T, Ramos Varrone G and Lopes Britto R. Immunotherapy using PD-1\/PDL-1 inhibitors in metastatic triple-negative breast cancer: a systematic review. Oncol Rev 2021; 15: 497.","DOI":"10.4081\/oncol.2021.497"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Dixon-Douglas J and Loi S. Immunotherapy in early-stage triple-negative breast cancer: where are we now and where are we headed? Curr Treat Options Oncol 2023; 24: 1004-1020.","DOI":"10.1007\/s11864-023-01087-y"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"113610","DOI":"10.1016\/j.biopha.2022.113610","article-title":"Natural products as chemo-radiation therapy sensitizers in cancers","volume":"154","author":"Nisar","year":"2022","unstructured":"Nisar S, Masoodi T, Prabhu KS, Kuttikrishnan S, Zarif L, Khatoon S, Ali S, Uddin S, Akil AA, Singh M, Macha MA and Bhat AA. Natural products as chemo-radiation therapy sensitizers in cancers. Biomed Pharmacother 2022; 154: 113610.","journal-title":"Biomed Pharmacother"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/biomedicines9101353","article-title":"Targeting drug chemo-resistance in cancer using natural products","volume":"9","author":"Talib","year":"2021","unstructured":"Talib WH, Alsayed AR, Barakat M, Abu-Taha MI and Mahmod AI. Targeting drug chemo-resistance in cancer using natural products. Biomedicines 2021; 9: 1353.","journal-title":"Biomedicines"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1177\/1534735417753542","article-title":"Benefit of adjuvant traditional herbal medicine with chemotherapy for resectable gastric cancer","volume":"17","author":"Lee","year":"2018","unstructured":"Lee YK, Bae K, Yoo HS and Cho SH. Benefit of adjuvant traditional herbal medicine with chemotherapy for resectable gastric cancer. Integr Cancer Ther 2018; 17: 619-627.","journal-title":"Integr Cancer Ther"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","unstructured":"Newman DJ and Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod 2020; 83: 770-803.","journal-title":"J Nat Prod"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"113249","DOI":"10.1016\/j.jep.2020.113249","article-title":"The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer","volume":"264","author":"Yang","year":"2021","unstructured":"Yang Z, Zhang Q, Yu L, Zhu J, Cao Y and Gao X. The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer. J Ethnopharmacol 2021; 264: 113249.","journal-title":"J Ethnopharmacol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1039\/C9NP00011A","article-title":"Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2","volume":"36","author":"Caesar","year":"2019","unstructured":"Caesar LK and Cech NB. Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2. Nat Prod Rep 2019; 36: 869-888.","journal-title":"Nat Prod Rep"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Anwar S, Malik JA, Ahmed S, Kameshwar VA, Alanazi J, Alamri A and Ahemad N. Can natural products targeting emt serve as the future anticancer therapeutics? Molecules 2022; 27: 7668.","DOI":"10.3390\/molecules27227668"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"113774","DOI":"10.1016\/j.biopha.2022.113774","article-title":"EMT mechanism in breast cancer metastasis and drug resistance: revisiting molecular interactions and biological functions","volume":"155","author":"Hashemi","year":"2022","unstructured":"Hashemi M, Arani HZ, Orouei S, Fallah S, Ghorbani A, Khaledabadi M, Kakavand A, Tavakolpournegari A, Saebfar H, Heidari H, Salimimoghadam S, Entezari M, Taheriazam A and Hushmandi K. EMT mechanism in breast cancer metastasis and drug resistance: revisiting molecular interactions and biological functions. Biomed Pharmacother 2022; 155: 113774.","journal-title":"Biomed Pharmacother"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3892\/ijo.32.5.1085","article-title":"Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells","volume":"32","author":"Sigstedt","year":"2008","unstructured":"Sigstedt SC, Hooten CJ, Callewaert MC, Jenkins AR, Romero AE, Pullin MJ, Kornienko A, Lowrey TK, Slambrouck SV and Steelant WFA. Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells. Int J Oncol 2008; 32: 1085-1090.","journal-title":"Int J Oncol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1074\/jbc.M113.496844","article-title":"Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin","volume":"289","author":"Antony","year":"2014","unstructured":"Antony ML, Lee J, Hahm ER, Kim SH, Marcus AI, Kumari V, Ji X, Yang Z, Vowell CL, Wipf P, Uechi GT, Yates NA, Romero G, Sarkar SN and Singh SV. Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin. J Biol Chem 2014; 289: 1852-1865.","journal-title":"J Biol Chem"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.3390\/ijms21114090","article-title":"Chrysosplenol d, a flavonol from artemisia annua, induces ERK1\/2-mediated apoptosis in triple negative human breast cancer cells","volume":"21","author":"Lang","year":"2020","unstructured":"Lang SJ, Schmiech M, Hafner S, Paetz C, Werner K, El Gaafary M, Schmidt CQ, Syrovets T and Simmet T. Chrysosplenol d, a flavonol from artemisia annua, induces ERK1\/2-mediated apoptosis in triple negative human breast cancer cells. Int J Mol Sci 2020; 21: 4090.","journal-title":"Int J Mol Sci"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3390\/antiox11040709","article-title":"Polyphenolic compounds from Lespedeza bicolor protect neuronal cells from oxidative stress","volume":"11","author":"Tarbeeva","year":"2022","unstructured":"Tarbeeva DV, Pislyagin EA, Menchinskaya ES, Berdyshev DV, Kalinovskiy AI, Grigorchuk VP, Mishchenko NP, Aminin DL and Fedoreyev SA. Polyphenolic compounds from Lespedeza bicolor protect neuronal cells from oxidative stress. Antioxidants (Basel) 2022; 11: 709.","journal-title":"Antioxidants (Basel)"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.fitote.2019.04.003","article-title":"Cytotoxic polyphenolic compounds from Lespedeza bicolor stem bark","volume":"135","author":"Tarbeeva","year":"2019","unstructured":"Tarbeeva DV, Fedoreyev SA, Veselova MV, Blagodatski AS, Klimenko AM, Kalinovskiy AI, Grigorchuk VP, Berdyshev DV and Gorovoy PG. Cytotoxic polyphenolic compounds from Lespedeza bicolor stem bark. Fitoterapia 2019; 135: 64-72.","journal-title":"Fitoterapia"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Paing YMM, Valencia M, Cho N and Lee SH. Preventive effect of 1-methoxylespeflorin G11 on nitrite release in lipopolysaccharide-stimulated glial cells. Nat Prod Commun 2023; 18: 1934578X231176150.","DOI":"10.1177\/1934578X231176150"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.3390\/antiox12101809","article-title":"7 macrophages","volume":"12","author":"Ren","year":"2023","unstructured":"Ren C, Li Q, Luo T, Betti M, Wang M, Qi S, Wu L and Zhao L. Antioxidant polyphenols from Lespedeza bicolor Turcz. Honey: anti-inflammatory effects on lipopolysaccharide-treated RAW 264.7 macrophages. Antioxidants (Basel) 2023; 12: 1809.","journal-title":"Antioxidants (Basel)"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"836417","DOI":"10.3389\/fmolb.2022.836417","article-title":"Triple-negative breast cancer: a brief review about epidemiology, risk factors, signaling pathways, treatment and role of artificial intelligence","volume":"9","author":"Almansour","year":"2022","unstructured":"Almansour NM. Triple-negative breast cancer: a brief review about epidemiology, risk factors, signaling pathways, treatment and role of artificial intelligence. Front Mol Biosci 2022; 9: 836417.","journal-title":"Front Mol Biosci"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41523-023-00564-9","article-title":"RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer","volume":"9","author":"Magna","year":"2023","unstructured":"Magna M, Hwang GH, McIntosh A, Drews-Elger K, Takabatake M, Ikeda A, Mera BJ, Kwak T, Miller P, Lippman ME and Hudson BI. RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer. NPJ Breast Cancer 2023; 9: 59.","journal-title":"NPJ Breast Cancer"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40164-023-00446-7","article-title":"Focal adhesion kinase: from biological functions to therapeutic strategies","volume":"12","author":"Tan","year":"2023","unstructured":"Tan X, Yan Y, Song B, Zhu S, Mei Q and Wu K. Focal adhesion kinase: from biological functions to therapeutic strategies. Exp Hematol Oncol 2023; 12: 83.","journal-title":"Exp Hematol Oncol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"347","DOI":"10.4161\/cam.3.4.9458","article-title":"The role of focal adhesion kinase in tumor initiation and progression","volume":"3","author":"Provenzano","year":"2009","unstructured":"Provenzano PP and Keely PJ. The role of focal adhesion kinase in tumor initiation and progression. Cell Adh Migr 2009; 3: 347-350.","journal-title":"Cell Adh Migr"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3390\/ijms23031726","article-title":"FAK in cancer: from mechanisms to therapeutic strategies","volume":"23","author":"Chuang","year":"2022","unstructured":"Chuang HH, Zhen YY, Tsai YC, Chuang CH, Hsiao M, Huang MS and Yang CJ. FAK in cancer: from mechanisms to therapeutic strategies. Int J Mol Sci 2022; 23: 1726.","journal-title":"Int J Mol Sci"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s12276-020-0447-4","article-title":"Targeting focal adhesion kinase in cancer cells and the tumor microenvironment","volume":"52","author":"Murphy","year":"2020","unstructured":"Murphy JM, Rodriguez YAR, Jeong K, Ahn EE and Lim SS. Targeting focal adhesion kinase in cancer cells and the tumor microenvironment. Exp Mol Med 2020; 52: 877-886.","journal-title":"Exp Mol Med"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.addr.2010.11.001","article-title":"Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis","volume":"63","author":"Zhao","year":"2011","unstructured":"Zhao X and Guan JL. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev 2011; 63: 610-615.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","article-title":"Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies","volume":"8","author":"ME","year":"2023","unstructured":"Bahar ME, Kim HJ and Kim DR. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther 2023; 8: 455.","journal-title":"Signal Transduct Target Ther"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1515\/bmc-2011-0049","article-title":"Focal adhesion kinase-regulated signaling events in human cancer","volume":"3","author":"Fu","year":"2012","unstructured":"Fu W, Hall JE and Schaller MD. Focal adhesion kinase-regulated signaling events in human cancer. Biomol Concepts 2012; 3: 225-240.","journal-title":"Biomol Concepts"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"9231057","DOI":"10.1155\/2016\/9231057","article-title":"Functions of the tumor suppressors p53 and Rb in actin cytoskeleton remodeling","volume":"2016","author":"Ebata","year":"2016","unstructured":"Ebata T, Hirata H and Kawauchi K. Functions of the tumor suppressors p53 and Rb in actin cytoskeleton remodeling. Biomed Res Int 2016; 2016: 9231057.","journal-title":"Biomed Res Int"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/jcm8010038","article-title":"FAK is required for tumor metastasis-related fluid microenvironment in triple-negative breast cancer","volume":"8","author":"Pan","year":"2019","unstructured":"Pan MR, Hou MF, Ou-Yang F, Wu CC, Chang SJ, Hung WC, Yip HK and Luo CW. FAK is required for tumor metastasis-related fluid microenvironment in triple-negative breast cancer. J Clin Med 2019; 8: 38.","journal-title":"J Clin Med"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"7058","DOI":"10.3390\/cimb45090446","article-title":"Targeting FAK\/PYK2 with SJP1602 for anti-tumor activity in triple-negative breast cancer","volume":"45","author":"Jeon","year":"2023","unstructured":"Jeon M, Hong S, Cho H, Park H, Lee SM and Ahn S. Targeting FAK\/PYK2 with SJP1602 for anti-tumor activity in triple-negative breast cancer. Curr Issues Mol Biol 2023; 45: 7058-7074.","journal-title":"Curr Issues Mol Biol"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Jing Y, Zhou Q, Zhu H, Zhang Y, Song Y, Zhang X, Huang X, Yang Y, Ni Y and Hu Q. Ki-67 is an independent prognostic marker for the recurrence and relapse of oral squamous cell carcinoma. Oncol Lett 2019; 17: 974-980.","DOI":"10.3892\/ol.2018.9647"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.canlet.2011.12.025","article-title":"Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research","volume":"327","author":"Ivashkevich","year":"2012","unstructured":"Ivashkevich A, Redon CE, Nakamura AJ, Martin RF and Martin OA. Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research. Cancer Lett 2012; 327: 123-133.","journal-title":"Cancer Lett"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1369\/0022155414561498","article-title":"Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights","volume":"63","author":"Yoon","year":"2015","unstructured":"Yoon H, Dehart JP, Murphy JM and Lim ST. Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights. J Histochem Cytochem 2015; 63: 114-128.","journal-title":"J Histochem Cytochem"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3390\/ph13120476","article-title":"Leaf extract and its bioactive constituents citronellol and, citronellal on the triple negative breast cancer MDA-MB-231 cell line","volume":"13","author":"Ho","year":"2020","unstructured":"Ho Y, Suphrom N, Daowtak K, Potup P, Thongsri Y and Usuwanthim K. Anticancer effect of citrus hystrix DC. Leaf extract and its bioactive constituents citronellol and, citronellal on the triple negative breast cancer MDA-MB-231 cell line. Pharmaceuticals (Basel) 2020; 13: 476.","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12906-020-03120-1","article-title":"cherimola on MDA-MB-231 breast cancer cell line","volume":"20","author":"Younes","year":"2020","unstructured":"Younes M, Ammoury C, Haykal T, Nasr L, Sarkis R and Rizk S. The selective anti-proliferative and pro-apoptotic effect of A. cherimola on MDA-MB-231 breast cancer cell line. BMC Complement Med Ther 2020; 20: 343.","journal-title":"BMC Complement Med Ther"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1080\/01635581.2020.1814825","article-title":"Holothuria scabra extract induces cell apoptosis and suppresses Warburg effect by down-regulating Akt\/mTOR\/HIF-1 axis in MDA-MB-231 breast cancer cells","volume":"73","author":"Yurasakpong","year":"2021","unstructured":"Yurasakpong L, Apisawetakan S, Pranweerapaiboon K, Sobhon P and Chaithirayanon K. Holothuria scabra extract induces cell apoptosis and suppresses Warburg effect by down-regulating Akt\/mTOR\/HIF-1 axis in MDA-MB-231 breast cancer cells. Nutr Cancer 2021; 73: 1964-1975.","journal-title":"Nutr Cancer"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/01635581.2020.1773511","article-title":"Hexane extract of Garcinia quaesita fruits induces apoptosis in breast cancer stem cells isolated from triple negative breast cancer cell line MDA-MB-231","volume":"73","author":"Colamba Pathiranage","year":"2021","unstructured":"Colamba Pathiranage V, Lowe JN, Rajagopalan U, Ediriweera MK, Senathilake K, Piyathilaka P, Tennekoon KH and Samarakoon SR. Hexane extract of Garcinia quaesita fruits induces apoptosis in breast cancer stem cells isolated from triple negative breast cancer cell line MDA-MB-231. Nutr Cancer 2021; 73: 845-855.","journal-title":"Nutr Cancer"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"994025","DOI":"10.3389\/fphar.2022.994025","article-title":"leaves exhibits potent anti-breast cancer potential and robust antioxidant properties","volume":"13","author":"Mesmar","year":"2022","unstructured":"Mesmar J, Abdallah R, Hamade K, Baydoun S, Al-Thani N, Shaito A, Maresca M, Badran A and Baydoun E. Ethanolic extract of Origanum syriacum L. leaves exhibits potent anti-breast cancer potential and robust antioxidant properties. Front Pharmacol 2022; 13: 994025.","journal-title":"Front Pharmacol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"154856","DOI":"10.1016\/j.phymed.2023.154856","article-title":"Ethyl acetate extract of Antenoron Filiforme inhibits the proliferation of triple negative breast cancer cells via suppressing Skp2\/p21 signaling axis","volume":"116","author":"Liao","year":"2023","unstructured":"Liao Y, Li S, An J, Yu X, Tan X, Gui Y, Wang Y, Huang L, Zhou S and Wang D. Ethyl acetate extract of Antenoron Filiforme inhibits the proliferation of triple negative breast cancer cells via suppressing Skp2\/p21 signaling axis. Phytomedicine 2023; 116: 154856.","journal-title":"Phytomedicine"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1331843","DOI":"10.3389\/fphar.2024.1331843","article-title":"Fractionation and phytochemical composition of an ethanolic extract of Ziziphus nummularia leaves: antioxidant and anticancerous properties in human triple negative breast cancer cells","volume":"15","author":"Abdallah","year":"2024","unstructured":"Abdallah R, Shaito AA, Badran A, Baydoun S, Sobeh M, Ouchari W, Sahri N, Eid AH, Mesmar JE and Baydoun E. Fractionation and phytochemical composition of an ethanolic extract of Ziziphus nummularia leaves: antioxidant and anticancerous properties in human triple negative breast cancer cells. Front Pharmacol 2024; 15: 1331843.","journal-title":"Front Pharmacol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"118389","DOI":"10.1016\/j.jep.2024.118389","article-title":"flower induces intracellular ROS, promotes DNA damage and apoptosis in triple negative breast cancer cells","volume":"332","author":"Guha","year":"2024","unstructured":"Guha S, Talukdar D, Mandal GK, Mukherjee R, Ghosh S, Naskar R, Saha P, Murmu N and Das G. Crude extract of Ruellia tuberosa L. flower induces intracellular ROS, promotes DNA damage and apoptosis in triple negative breast cancer cells. J Ethnopharmacol 2024; 332: 118389.","journal-title":"J Ethnopharmacol"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/9\/ajcr0159184.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:56:14Z","timestamp":1766022974000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/9\/ajcr0159184.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":79,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/mypg4066","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}